Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | USP14 | P54578 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22739436 | 0.97 | USP14 (0.31) | KDM4EMEN1MAPTKMT2AUSP14 | |
| SCHEMBL22740245 | 0.92 | NCEH1 (0.31) | KDM4EMEN1MAPTKMT2AUSP14 | |
| SCHEMBL22739396 | 0.91 | PGR (0.32) | KDM4EMEN1MAPTKMT2AUSP14 | |
| SCHEMBL22740964 | 0.91 | PGR (0.34) | KDM4EMEN1MAPTKMT2APGR | |
| SCHEMBL22739431 | 0.91 | TBK1 (0.33) | KDM4EMEN1MAPTKMT2A | |
| SCHEMBL22741039 | 0.90 | PGR (0.30) | PGR | |
| SCHEMBL21870443 | 0.90 | MAOB (0.31) | KDM4EMEN1MAPTKMT2AUSP14 | |
| SCHEMBL22742200 | 0.87 | TBK1 (0.32) | — | |
| SCHEMBL22740770 | 0.87 | PGR (0.33) | KDM4EMEN1MAPTKMT2APGR | |
| SCHEMBL21870041 | 0.86 | HRH3 (0.32) | KDM4EMEN1MAPTKMT2AUSP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200377513-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200377513-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | PIEZO1, TMEM109, LEF1 | KDM4E 3079/4885MEN1 612/4885MAPT 2589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.